Trial Profile
Optimal Lag Time Study: Optimal timing of rapid-acting insulin analogues administration before meals.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2014
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms OLTS
- 24 Sep 2010 Results presented at the 46th Annual Meeting of the European Association for the Study of Diabetes.
- 29 Mar 2010 New trial record